Sun Pharma to market Zydus' novel anti-CKD drug desidustat in India

“The addition of RYTSTAT further strengthens our nephrology portfolio in India," said Kirti Ganorkar, CEO - India Business, Sun Pharma.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/xn07hJU
via IFTTT